三星医疗1月30日获融资买入3649.60万元，融资余额2.93亿元

Group 1 - On January 30, Samsung Medical experienced a decline of 3.51% with a trading volume of 463 million yuan, and a net financing buy of -8.20 million yuan for the day [1] - As of January 30, the total financing and securities lending balance for Samsung Medical was 299 million yuan, with a financing balance of 293 million yuan, accounting for 0.88% of the circulating market value [1] - The company’s main business revenue composition includes 79.70% from the power sector, 19.15% from medical services, and 1.15% from other businesses [1] Group 2 - As of October 31, the number of shareholders for Samsung Medical was 33,500, with an average of 41,941 circulating shares per person [2] - For the period from January to September 2025, Samsung Medical reported a revenue of 11.08 billion yuan, representing a year-on-year growth of 6.19%, while the net profit attributable to the parent company decreased by 15.85% to 1.528 billion yuan [2] - Since its A-share listing, Samsung Medical has distributed a total of 6.407 billion yuan in dividends, with 3.329 billion yuan distributed in the last three years [3]